Precision Medicine News and Research

RSS

Machine learning paves the way for precision medicine in UTI treatments

Machine learning (ML) algorithms that predict antibiotic resistance in complicated urinary tract infections.

6 Nov 2023

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a sweeping assessment of the state of the field around the world.

6 Nov 2023

CN Bio appoints Neil Rumbelow as Director of Product Development

CN Bio appoints Neil Rumbelow as Director of Product Development.

From CN-Bio 2 Nov 2023

New study provides insights about mosaic chromosomal alterations in diverse populations

As people age, the DNA in their cells begins to accumulate genetic mutations. Mosaic chromosomal alterations (mCAs), a category of mutations acquired in blood cells, are linked with a 10-fold increased risk of developing blood cancer.

1 Nov 2023

New AI tool could lead to precision medicine by predicting drug response

An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult.

31 Oct 2023

Study offers the most comprehensive look to date on prostate cancer disparities

Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status.

27 Oct 2023

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

City of Hope, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer.

26 Oct 2023

Researchers to develop machine models to predict cardiometabolic risks in young people

A researcher at Binghamton University, State University of New York will lead a $2.5 million project from the National Institutes of Health to develop machine models to identify and predict cardiometabolic risks in adolescents and young adults.

26 Oct 2023

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

From Sino Biological Inc. 24 Oct 2023

Dr. Anthony Lang reveals new model for studying Parkinson’s disease at the 26th World Congress of Neurology

During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research, University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinson’s disease. This new approach will help researchers investigate biological aspects of the disease that may be detectable many years before symptoms begin to show.

20 Oct 2023

Finding the correlation between cancer and stroke risk

Patients with a previous or current cancer diagnosis are more likely to have a stroke than the general population, but how are specific cancers and treatments associated with stroke risk?

16 Oct 2023

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

Hackensack University Medical Center has established the Center for Weight Loss and Metabolic Health, an integrated program to help people who have struggled to lose weight to achieve and maintain their weight loss goals.

13 Oct 2023

AI-based method shows promise for precision medicine

Artificial intelligence, AI, which finds patterns in complex biological data could eventually contribute to the development of individually tailored healthcare.

12 Oct 2023

Does your gut microbiome play a role in therapeutic outcomes?

The role of the gut microbiome and its metabolites in altering the therapeutic outcomes

12 Oct 2023

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published in Oncotarget's Volume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells."

11 Oct 2023

Study sheds light on how the immune system differentiates between self and non-self antigens

A groundbreaking study, led by Professor Kyemyung Park and his research team in the Graduate School of Health Science and Technology and the Department of Biomedical Engineering at UNIST has shed light on the intricate mechanism behind the immune system's ability to differentiate between self and non-self antigens.

11 Oct 2023

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

The intricate interactions between gut microbiota and drugs.

11 Oct 2023

Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.

From Owlstone Medical Ltd 10 Oct 2023

The use of artificial intelligence and natural language processing for mental health interventions

Natural Language Processing (NLP) to examine mental health interventions (MHI).

10 Oct 2023

Liquid biopsies could be used as an early marker of immunotherapy response, study finds

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).

9 Oct 2023

Precision Medicine News and Research

Machine learning paves the way for precision medicine in UTI treatments

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

CN Bio appoints Neil Rumbelow as Director of Product Development

New study provides insights about mosaic chromosomal alterations in diverse populations

New AI tool could lead to precision medicine by predicting drug response

Study offers the most comprehensive look to date on prostate cancer disparities

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

Researchers to develop machine models to predict cardiometabolic risks in young people

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

Dr. Anthony Lang reveals new model for studying Parkinson’s disease at the 26th World Congress of Neurology

Finding the correlation between cancer and stroke risk

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

AI-based method shows promise for precision medicine

Does your gut microbiome play a role in therapeutic outcomes?

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

Study sheds light on how the immune system differentiates between self and non-self antigens

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

The use of artificial intelligence and natural language processing for mental health interventions

Liquid biopsies could be used as an early marker of immunotherapy response, study finds

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News